By reducing protein kinase B (AKT) phosphorylation levels in colon cancer cells, it was found that these AMTs had low toxicity against normal colon cells and effectively inhibited the proliferation of HT-29 cancer cells (Zbakh et al. 2020). The gene discussed is AKT1; the disease is colonic neoplasm.